EUVIMEDEUVIMED entdecken
Systematische Übersicht

N-Acetylcysteine in traumatic and hypoxic brain injury: A systematic review of neuroprotective mechanisms and clinical evidence

Prithpal Singh Matreja, Sanjeev Kumar Jain, Vinod Kumar Singh, Usha Kiran Pothu

Indian Journal of Physiology and Pharmacology · 26.05.2026 · 1-14

DOI: 10.25259/ijpp_172_2025 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Indian Journal of Physiology and Pharmacology, online erschienen am 26.05.2026. Verfasst von Prithpal Singh Matreja und 3 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Traumatic brain injury (TBI) and hypoxic-ischemic encephalopathy (HIE) participate in a mutual pathophysiological connection of oxidative stress, neuroinflammatory response and mitochondrial damage which leads to the development of long-term neurologic deficits. N-acetylcysteine (NAC), which is a precursor to glutathione (GSH), has been proposed to exert neuroprotective outcomes by controlling oxidative stress, neuroinflammation and mitochondrial function. Material and Methods: This systematic review was guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines. Demographic data, intervention process, pharmacokinetics, biomarker measurement, clinical outcomes and mechanistic information were extracted from the data. Risk of bias 2 (RoB 2.0) and RoB in non-randomised studies (ROBINS)-I instruments were used to assess the RoB. Sensitivity analyses using the leave-one-out method were conducted to investigate the robustness of the results.

Results

The six trials included, and then combined, in our analysis consisted of diverse populations with 12–81-patient sample sizes and 48-h to 6-month follow-up periods. Administration routes included oral, intravenous and naso/orogastric routes with dose regimens ranging from 25 mg/kg to 140 mg/kg loading doses. Achieved NAC serum levels ranged from 16,977 to 18,447 ng/mL, while cerebrospinal fluid concentrations ranged from 269 to 468 ng/mL. Significantly elevated levels of GSH were achieved, representing an increase of a mean of 0.30 ± 0.21 mM ( p < 0.0001), and cognitive and functional recovery were facilitated by an odds ratio of 3.6 ( p = 0.006). The functional connectivity indices, fractional amplitude of low-frequency fluctuations, degree centrality and functional connectivity strength were statistically significantly improved ( p < 0.05), and evidence towards mechanistic benefit included GSH, glycolytic pathways and reductions in apoptosis-associated metabolites ( p < 0.01).

Conclusion

The results indicated that NAC had favourable pharmacokinetics, was tolerable and was responsible for antioxidant replenishment, improvement of cognition and restoration of functional brain networks in TBI and HIE patients. Results were still affected by study heterogeneity and heterogeneity of population characteristics and outcomes.

Zitieren

APA

Matreja, P. S., Jain, S. K., Singh, V. K., & Pothu, U. K. (2026). N-Acetylcysteine in traumatic and hypoxic brain injury: A systematic review of neuroprotective mechanisms and clinical evidence. Indian Journal of Physiology and Pharmacology, 0, 1-14. https://doi.org/10.25259/ijpp_172_2025

Vancouver

Matreja PS, Jain SK, Singh VK, Pothu UK. N-Acetylcysteine in traumatic and hypoxic brain injury: A systematic review of neuroprotective mechanisms and clinical evidence. Indian Journal of Physiology and Pharmacology. 2026;0:1-14. doi:10.25259/ijpp_172_2025

BibTeX
@article{Matreja2026,
  author = {Matreja, Prithpal Singh and Jain, Sanjeev Kumar and Singh, Vinod Kumar and Pothu, Usha Kiran},
  title = {N-Acetylcysteine in traumatic and hypoxic brain injury: A systematic review of neuroprotective mechanisms and clinical evidence},
  journal = {Indian Journal of Physiology and Pharmacology},
  year = {2026},
  volume = {0},
  pages = {1--14},
  doi = {10.25259/ijpp_172_2025}
}
Kostenlos starten →